Home › Funds › LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE › ELV

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reported holding 22,446 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 2.42% of its reported portfolio and ranking #17 among its reported holdings. LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)22.45K sh
Reported value held$8.73M
Portfolio Weight2.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's ELV position evolved

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE first disclosed a stake in ELV in Q3 2023 at 27,465 shares (US$12.0M). The position peaked in Q2 2024 at 27,283 shares, worth US$14.8M. Across 13 filings, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 22,446 shares valued at US$8.7M — a reduction of -1,753 shares quarter over quarter.. Notable position changes include a 53% trim in Q4 2025 (shares fell 16% over the following quarter), a 84% increase in Q1 2026 (shares rose 33% over the following quarter), a 35% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 27.46K $11.96M New
Q4 2023 27.28K $12.87M Reduce
Q1 2024 27.30K $14.15M Hold
Q2 2024 27.28K $14.78M Hold
Q3 2024 27.72K $14.41M Add
Q4 2024 32.09K $11.84M Add
Q1 2025 33.81K $14.70M Add
Q2 2025 34.61K $13.46M Add
Q3 2025 43.26K $13.98M Add
Q4 2025 20.21K $7.09M Reduce
Q1 2026 37.18K $10.88M Add
Q2 2026 24.20K $9.36M Reduce
Q3 2026 22.45K $8.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE held ELV?

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's current position in ELV?

As of Q3 2026, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE holds 22.45K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $8.73M, representing 2.42% of its reported portfolio and ranking #17.

Has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE been buying or selling ELV?

In the latest 13F filing (Q3 2026), LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reduced its position in ELV. The position peaked in Q2 2024 at 27.28K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.